Ono Pharmaceutical (OPHLY) Short Interest Ratio & Short Volume $3.61 -0.23 (-5.98%) As of 05/7/2025 03:51 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartSEC FilingsShort InterestBuy This Stock Ono Pharmaceutical Short Interest DataOno Pharmaceutical (OPHLY) has a short interest of 79,000 shares. This marks a 143.08% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 389,493 shares to cover all short positions.Current Short Interest79,000 sharesPrevious Short Interest32,500 sharesChange Vs. Previous Month+143.08%Dollar Volume Sold Short$316,790.00Short Interest Ratio0.1 Days to CoverLast Record DateApril 15, 2025Today's Trading Volume125,925 sharesAverage Trading Volume389,493 sharesToday's Volume Vs. Average32% Short Selling Ono Pharmaceutical? Sign up to receive the latest short interest report for Ono Pharmaceutical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartOPHLY Short Interest Over TimeOPHLY Days to Cover Over TimeOPHLY Percentage of Float Shorted Over Time Ono Pharmaceutical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202579,000 shares $316,790.00 +143.1%N/A0.1 $4.01 3/31/202532,500 shares $117,000.00 -57.6%N/A0.1 $3.60 3/15/202576,600 shares $281,880.34 +153.6%N/A0.2 $3.68 2/28/202530,200 shares $108,116.00 -25.6%N/A0 $3.58 2/15/202540,600 shares $137,634.00 -28.7%N/A0 $3.39 1/31/202556,900 shares $193,460.00 -69.5%N/A0.1 $3.40 1/15/2025186,600 shares $641,904.00 +51.6%N/A0.1 $3.44 12/31/2024123,100 shares $428,388.00 -44.8%N/A0.1 $3.48 12/15/2024222,900 shares $800,211.00 +747.5%N/A0.2 $3.59 11/30/202426,300 shares $99,940.00 -82.6%N/A0 $3.80 Get the Latest News and Ratings for OPHLY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ono Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 11/15/2024151,000 shares $585,880.00 +89.5%N/A0.1 $3.88 10/31/202479,700 shares $329,161.00 -73.4%N/A0.1 $4.13 10/15/2024299,800 shares $1.31 million +1,663.5%N/A0.7 $4.38 9/30/202417,000 shares $74,460.00 +246.9%N/A0.1 $4.38 9/15/20244,900 shares $21,707.00 -35.5%N/A0 $4.43 8/31/20247,600 shares $37,240.00 -32.7%N/A0.1 $4.90 8/15/202411,300 shares $54,579.00 -87.9%N/A0 $4.83 7/31/202493,000 shares $451,515.00 -46.5%N/A0.6 $4.86 7/15/2024173,700 shares $826,812.00 +12.1%N/A0.4 $4.76 6/30/2024155,000 shares $705,250.00 -16.6%N/A0.3 $4.55 6/15/2024185,900 shares $829,114.00 +317.8%N/A0.6 $4.46 5/31/202444,500 shares $212,265.00 +19.6%N/A0.1 $4.77 5/15/202437,200 shares $183,768.00 +126.8%N/A0.2 $4.94 4/30/202416,400 shares $77,572.00 -64.7%N/A0 $4.73 4/15/202446,500 shares $231,570.00 +123.6%N/A0.2 $4.98 3/31/202420,800 shares $113,152.00 -23.8%N/A0.1 $5.44 3/15/202427,300 shares $152,061.00 -15.5%N/A0.2 $5.57 2/29/202432,300 shares $175,712.00 +412.7%N/A0.1 $5.44 2/15/20246,300 shares $33,264.00 -32.3%N/A0 $5.28 1/15/20243,100 shares $18,799.95 +106.7%N/A0 $6.06 12/31/20231,500 shares $8,790.00 -96.9%N/A0 $5.86 12/15/202347,800 shares $279,630.00 -38.2%N/A0.3 $5.85 11/30/202377,300 shares $472,303.00 +1,580.4%N/A0.5 $6.11 11/15/20234,600 shares $26,910.00 No ChangeN/A0 $5.85 10/15/20232,600 shares $15,964.00 -89.1%N/A0 $6.14 9/30/202323,900 shares $152,243.00 -15.9%N/A0.2 $6.37 9/15/202328,400 shares $186,872.00 -55.9%N/A0.2 $6.58 8/31/202364,400 shares $407,008.00 -61.4%N/A0.2 $6.32 8/15/2023166,900 shares $1.07 million +120.2%N/A0.6 $6.41 7/31/202375,800 shares $462,834.80 +6.6%N/A0.5 $6.113..2..1.. AI 2.0 ignition (don’t sleep on this) (Ad)I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring. Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 7/15/202371,100 shares $435,132.00 +284.3%N/A0.3 $6.12 6/30/202318,500 shares $110,260.00 +143.4%N/A0.1 $5.96 6/15/20237,600 shares $48,032.00 -68.2%N/A0 $6.32 5/31/202323,900 shares $147,702.00 No ChangeN/A0.1 $6.18 4/30/2023300 shares $1,989.00 -98.2%N/A0 $6.63 4/15/202316,300 shares $111,492.00 -88.8%N/A0.1 $6.84 3/31/2023145,000 shares $1.00 million +18.7%N/A0.7 $6.93 3/15/2023122,200 shares $843,180.00 +1,320.9%N/A0.3 $6.90 2/28/20238,600 shares $57,792.00 +196.6%N/A0 $6.72 2/15/20232,900 shares $20,532.00 No ChangeN/A0 $7.08 1/15/20235,900 shares $43,542.00 -70.1%N/A0 $7.38 12/30/202219,700 shares $151,099.00 -47.0%N/A0.5 $7.67 12/15/202237,200 shares $306,156.00 -17.2%N/A1.8 $8.23 11/30/202244,900 shares $380,752.00 +153.7%N/A1.5 $8.48 11/15/202217,700 shares $138,414.00 -50.8%N/A0.2 $7.82 10/31/202236,000 shares $279,360.00 -60.8%N/A0.3 $7.76 10/15/202291,800 shares $712,368.00 -16.7%N/A0.6 $7.76 9/30/2022110,200 shares $857,356.00 +357.3%N/A0.5 $7.78 9/15/202224,100 shares $184,003.50 +270.8%N/A0.2 $7.64 8/31/20226,500 shares $51,155.00 -67.7%N/A0.1 $7.87 8/15/202220,100 shares $169,965.60 -64.4%N/A0.6 $8.46 7/31/202256,500 shares $526,297.50 -41.2%N/A0.7 $9.32 7/15/202296,100 shares $904,301.00 +71.9%N/A2.1 $9.41 6/30/202255,900 shares $471,796.00 -23.8%N/A0.7 $8.44 6/15/202273,400 shares $588,668.00 -12.6%N/A1 $8.02 5/31/202284,000 shares $738,528.00 +3.1%N/A4.1 $8.79 5/15/202281,500 shares $695,195.00 +65.0%N/A1.4 $8.53 4/30/202249,400 shares $418,912.00 +94.5%N/A1.2 $8.48 4/15/202225,400 shares $214,833.20 +1.2%N/A0.9 $8.46 3/31/202225,100 shares $208,455.50 +61.9%N/A1 $8.31 3/15/202215,500 shares $130,045.00 -56.8%N/A0.3 $8.39 2/28/202235,900 shares $297,611.00 +97.3%N/A0.8 $8.29 2/15/202218,200 shares $151,788.00 +104.5%N/A0.3 $8.34 1/31/20228,900 shares $71,645.00 -64.5%N/A0.1 $8.05 1/15/202225,100 shares $207,075.00 +94.6%N/A0.4 $8.25 12/31/202112,900 shares $106,683.00 -78.6%N/A0.2 $8.27 12/15/202160,400 shares $495,219.60 +37.0%N/A0.4 $8.20 11/30/202144,100 shares $322,812.00 +59.8%N/A0.3 $7.32 11/15/202127,600 shares $199,272.00 +213.6%N/A0.3 $7.22 10/29/20218,800 shares $60,896.00 No ChangeN/A0.1 $6.92 9/30/20212,700 shares $20,385.00 -76.3%N/A0.1 $7.55 9/15/202111,400 shares $92,340.00 -47.2%N/A0.3 $8.10 8/31/202121,600 shares $172,800.00 -54.2%N/A0.4 $8.00 8/13/202147,200 shares $357,540.00 +391.7%N/A0.3 $7.58 7/30/20219,600 shares $74,688.00 -72.4%N/A0.1 $7.78 7/15/202134,800 shares $264,828.00 +728.6%N/A0.3 $7.61 6/30/20214,200 shares $31,004.40 +2.4%N/A0.1 $7.38 6/15/20214,100 shares $31,160.00 -62.4%N/A0 $7.60 5/28/202110,900 shares $82,295.00 -60.5%N/A0.1 $7.55 5/14/202127,600 shares $209,760.00 +2.6%N/A0.2 $7.603..2..1.. AI 2.0 ignition (don’t sleep on this) (Ad)I just put together an urgent new presentation that you need to see right away. In short: I believe we are mere days away from a critical announcement from a key tech leader… One that will officially ignite “AI 2.0” – and potentially send a whole new class of stocks soaring. Click to find out what Nvidia’s CEO might reveal… and how Sykes is preparing to ride the wave. 4/30/202126,900 shares $223,135.50 -24.2%N/A0.4 $8.30 4/15/202135,500 shares $305,655.00 +7,000.0%N/A0.6 $8.61 3/31/2021500 shares $4,352.50 -73.7%N/A0 $8.71 3/15/20211,900 shares $16,530.00 -32.1%N/A0.1 $8.70 2/26/20212,800 shares $25,704.00 +2,700.0%N/A0.3 $9.18 2/12/2021100 shares $990.00 -95.7%N/A0 $9.90 1/29/20212,300 shares $22,356.00 +2,200.0%N/A0.2 $9.72 1/15/2021700 shares $6,895.00 -12.5%N/A0 $9.85 12/31/2020100 shares $1,000.00 -85.7%N/A0 $10.00 12/15/2020700 shares $7,066.50 -12.5%N/A0 $10.10 11/30/2020800 shares $8,424.00 +60.0%N/A0.1 $10.53 11/15/2020500 shares $5,025.00 -58.3%N/A0.1 $10.05 10/30/20201,200 shares $12,042.00 -53.9%N/A0.1 $10.04 10/15/20202,600 shares $27,248.00 +116.7%N/A0.3 $10.48 9/30/20201,200 shares $12,362.40 +200.0%N/A0.1 $10.30 9/15/2020400 shares $4,120.00 -98.6%N/A0 $10.30 8/31/202027,900 shares $279,558.00 +1,541.2%N/A1 $10.02 8/14/20201,700 shares $17,272.00 -32.0%N/A0 $10.16 7/31/20202,500 shares $23,400.00 -77.1%N/A0.2 $9.36 7/15/202010,900 shares $101,424.50 +81.7%N/A1.7 $9.31 6/30/20206,000 shares $55,440.00 +150.0%N/A0.3 $9.24 6/15/20202,400 shares $22,564.80 -97.6%N/A0.2 $9.40 5/29/202099,500 shares $936,295.00 +529.8%N/A0.6 $9.41 5/15/202015,800 shares $133,984.00 +2,157.1%N/A0.2 $8.48 OPHLY Short Interest - Frequently Asked Questions What is Ono Pharmaceutical's current short interest? Short interest is the volume of Ono Pharmaceutical shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 79,000 shares of OPHLY short. Learn More on Ono Pharmaceutical's current short interest. Is Ono Pharmaceutical's short interest increasing or decreasing? Ono Pharmaceutical saw a increase in short interest in April. As of April 15th, there was short interest totaling 79,000 shares, an increase of 143.1% from the previous total of 32,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Ono Pharmaceutical stock? Short selling OPHLY is an investing strategy that aims to generate trading profit from Ono Pharmaceutical as its price is falling. OPHLY shares are trading down $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Ono Pharmaceutical? A short squeeze for Ono Pharmaceutical occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of OPHLY, which in turn drives the price of the stock up even further. How often is Ono Pharmaceutical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OPHLY, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies AZNCF Short Squeeze CSPCY Short Squeeze JCRRF Short Squeeze KYKOF Short Squeeze MAYNF Short Squeeze ORINF Short Squeeze OTSKY Short Squeeze OTSKF Short Squeeze PTKFF Short Squeeze RHHVF Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:OPHLY) was last updated on 5/8/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Seeing how the media and other analysts are covering Trump’s actions – it’s laughable. At least it would be la...Porter & Company | Sponsored270x more lucrative than NVIDIA???270x more lucrative than NVIDIA??? If you've missed out on NVIDIA's recent 1,600% run... Don't worry. ...Behind the Markets | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | SponsoredVanishing BenefitsWhat would you do if your next Social Security check simply never arrived? If you called and the line was d...Investors Alley | SponsoredSilver’s 332% Surge?Silver has quietly become one of the most promising investments of this cycle. Russia is now stockpiling silve...Lear Capital | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ono Pharmaceutical Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ono Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy OPHLY Stock Free OPHLY Stock Alerts